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Figure 3. Pedal and tail-pinch 
reflex presence by drug-ketamine 
combination and administration 
route over time post-induction. 
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Figure 2. Mean (a) loss of righting 
reflex (LORR) and (b) regain of 
righting reflex times (RORR) times 
by drug-ketamine combination and 
administration route. 
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Figure 1. Individual plots by mouse 
for (a) HR, (b) fr and (c) peripheral 
oxygen saturation (SpO2) by drug-
ketamine combination and 
administration route (IP or SC) over 
time post-induction used for 
statistical analysis. 
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Results & Discussion 
There were no significant differences in LORR or RORR times (p ≥ 0.077; Fig. 2). Anesthetic depth was monitored by tail-pinch and 
pedal reflexes. Loss of the tail-pinch reflex always occurred by 12 minutes post-induction and was not affected by treatment  (p = 
0.359; Fig. 3). Pedal reflex loss was not consistently achieved by either drug, but was more frequent with MK than DK over time (p = 
0.021; Fig. 3). In rats, medetomidine and dexmedetomidine alone did not induce sustainable pedal reflex loss.3  
Heart rate was not affected by treatment (Fig. 1a), but covaried with time and fr (p ≤ 0.002; Fig. 4a,b). Bradycardic effects were 
apparent for approximately 26 minutes post-induction; the HR increased thereafter. In the conscious dog, HR was similarly affected 
by medetomidine and dexmedetomidine alone.2 In tamarins, MK-treated individuals had a significantly higher HR over time.1 
The fr was significantly higher with MK than DK (Fig. 1b; p < 0.001), and increased as SpO2 decreased (Fig. 4b,c; p < 0.001). On 
observation, the depth of breath appeared more shallow over time; this may account for the increase in fr over time. No difference 
was seen in fr in conscious dogs treated with medetomidine or dexmedetomidine alone, but significantly reduced fr overall.2 
Mice injected IP had a significantly higher SpO2 (Fig. 1c; p = 0.040), but hypoxia was still evident. The SpO2 was positively correlated 
with bodyweight (p = 0.006) and significantly lower in males than females (p = 0.008). The SpO2 was negatively correlated with HR (p 
= 0.001), fr (p < 0.001), and time (p < 0.001; Fig. 4c). 
Hypoxia is a significant cause of mortality in anesthetized mice, yet supportive oxygen is not commonly used.4 Hypoxia was 
marked within 5 minutes post-induction (83.8 ± 6.7 % SpO2) and SpO2 decreased severely to 66.7 ± 7.5 % by 89 minutes (Fig. 4c). 
Conclusions 
§  There were no clinical advantages of dexmedetomidine over medetomidine in this study. 
§  The doses of MK and DK administered in this study do not appear to have provided appropriate anesthetic depth for 
surgical procedures. 
§  There were no clinical advantages of IP over SC administration as the onset and anesthetic depth were similar; 
therefore, the SC route is favorable to prevent damage to internal organs that may occur IP. 
§  All mice were markedly or severely hypoxic throughout this study. Always provide oxygen to prevent this. 
Introduction 
Medetomidine-ketamine (MK) and 
dexmedetomidine-ketamine (DK) are 
widely used to provide general 
anesthesia, yet have only been 
compared in the golden-headed lion 
tamarin.1 Similarly, medetomidine 
and dexmedetomidine alone have 
only been compared in the dog2 and 
rat3.  
Ketamine rapidly induces dissociative 
anesthesia while also providing 
analgesia; its side effects include 
minimal tachycardia, dysphoria,  and 
muscle rigidity.  
Medetomidine, a 1:1 racemic mixture 
of stereoisomers levomedetomidine 
and dexmedetomidine, is an α2 
agonist sedative and analgesic; its 
side effects include bradycardia, 
hypotension, respiratory depression, 
and diuresis. Dexmedetomidine is the 
active enantiomer of medetomidine.2 
Reversibility by atipamezole is a 
major advantage of these drugs. 
The objectives of this study were to 
compare the effects of MK and DK, 
administered IP or SC, on the 1) loss 
of the righting reflex (LORR); 2) tail-
pinch reflex; 3) pedal reflex; 4) heart 
rate (HR); 5) respiratory rate (fr); 6) 
peripheral oxygen saturation (SpO2), 
and 7) regain of the righting reflex 
(RORR)over time in mice. 
Methods 
Animals: Male (n = 10) and female (n 
= 10) C57BL/6N micea, weighing 21 ± 
2.3 g at the time of the study, were 
previously acclimated in a ventilated 
closed system for two weeks. 
Experimental Design: The mice 
underwent 4 anesthetic treatments in 
a randomized crossover design with ≥ 
48 hours between treatments; 
ketamineb (75 mg kg-1) was combined 
with medetomidinec (1 mg kg-1) or 
dexmedetomidined (0.5 mg kg-1) and 
injected IP or SC. 
Procedure: The LORR was recorded. 
Mice were placed on a heating pad 
without supportive oxygen. Tail-pinch 
and pedal reflexes, HR, fr, and SpO2 
were monitored for 89 minutes from 
5 minutes post-induction at 7-minute 
intervals with the pulse oximetere 
probe on the thigh. Atipamezolef (5 
mg kg-1) was administered to reverse 
anesthesia (same route as induction). 
The RORR was recorded. 
Statistical Analysis: General linear 
models were used to analyze LORR 
and RORR times. The presence of 
tail-pinch and pedal reflexes were 
evaluated with binomial generalized 
linear models. The HR, fr, and SpO2 
were examined with generalized 
additive mixed effects models which 
accounted for individual random 
variation among mice (Fig. 1). 
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Mouse was used as a random effect and a smoothing 
function was used for time. Temporal auto-correlation was 
identified by testing residuals with an auto-correlation 
function (acf); when necessary, a correlation structure was 
also added to the model to control this. Models were 
compared with and without mouse (random effect) and 
with time as a non-linear (with smoothing function) and a 
linear (without smoothing function) variable. Temporal 
correlation structures corCompSymm and corARMA were 
also compared. The optimal full model for each response 
variable was was selected by the lowest Akaike’s 
information criterion value.  
Figure 4. Mean (a) HR and (b) fr by 
drug-ketamine combination, and 
(c) peripheral oxygen saturation 
(SpO2) by administration route, over 
time post-induction. 
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